Brief: Lifemd Inc And Ascend Therapeutics Launch Integrated D2C Telehealth Model For Hormone Therapy
21/09/2023 11:04
Sept 21 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD INC - LIFEMD AND ASCEND THERAPEUTICS LAUNCH
INTEGRATED
DIRECT-TO-CONSUMER TELEHEALTH MODEL FOR HORMONE THERAPY
Source text for Eikon: ID:nGNXPkwQz
Further company coverage: LFMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US